CME Quiz

Published on: 
Supplements and Featured Publications, Oncology and Managed Care: Evolving Trends for Better Patient Care, Volume 11, Issue 17 Suppl

CME Questions

Oncology and Managed Care:Evolving Trends for Better Patient Care

Continuing Medical Education Accreditation

The University of Cincinnati College of Medicine designatesthis educational activity for a maximum of 2Category 1 credits toward the AMA Physician's RecognitionAward. Each physician should claim only those hoursthat he/she actually spends in the educational activity.

The University of Cincinnati College of Medicine isaccredited by the Accreditation Council for ContinuingMedical Education (ACCME) to sponsor medical educationfor physicians.


After reading "Oncology and Managed Care: EvolvingTrends for Better Patient Care," complete the program evaluationand select the 1 best answer to each of the followingquestions. A statement of continuing education hourswill be mailed to those who successfully complete (with aminimum score of 70%) the examination at the conclusionof the program.


1. Today, healthcare managers can predict cancer costs risingat annual rates of:

  1. 30%
  2. 20%
  3. 70%
  4. 85%

2. According to Dr Newcomer, to effectively improvepatient care and curtail spending, oncologists need to:

  1. See their cancer patients more often
  2. Increase the dosage of drugs given to patients
  3. Aggressively manage patients nearing end of life
  4. Reduce their dependence on prescribing high-costdrug treatments

3. In America each year, approximately 76% of new cancerdiagnoses occur in which group?

  1. Men 60 years of age or older
  2. Individuals 55 years of age or older
  3. African Americans 45 years of age or older
  4. Female cigarette smokers 50 years of age or older

4. Each year in the United States, how many people receivea diagnosis of cancer?

  1. Almost 4 million
  2. About 750 000
  3. Almost 1.4 million
  4. Nearly 8 million

5. Which types of cancer are diagnosed most often in theUnited States?

  1. Prostate, breast, lung, colon and rectum, andmelanoma
  2. Leukemia, lung, skin, and breast
  3. Lung, prostate, ovary, and breast
  4. Prostate, lymphoma, breast, skin, and lung

6. In the United States, the direct costs of cancer care onan annualized basis total:

  1. $70 billion
  2. $8 billion
  3. $90 million
  4. $15 billion

7. In 2005, the Centers for Medicare & Medicaid Servicesreleased 2 major coverage policies. One policy pertained tothe use of drugs and biologics in the treatment of colorectalcancer, and the other focused primarily on coverage for:

  1. Positron emission tomography in cancer care
  2. Colonoscopy as screening for colorectal cancer
  3. Mammographic screening for breast cancer
  4. Total-body skin-cancer screening

8. The antiangiogenic biologic approved in early 2004 bythe US Food and Drug Administration as a first-line treatmentfor colon and rectal cancer was:

  1. Oxaliplatin
  2. Gefitinib
  3. Bevacizumab
  4. Irinotecan

9. The formulary process has been applied to the availabilityand use of cancer drugs and biologics.

  1. True
  2. False

10. A major disincentive for the development of new chemicaland biologic oral formulations has been:

  1. Valid clinical data demonstrating that orallyadministered antineoplastic drugs lack the efficacyof those given parenterally
  2. The greater incidence of adverse effects associatedwith oral anticancer treatment
  3. The very limited coverage of oral agents underMedicare
  4. Difficulty in monitoring patient dosing and compliancewhen oral agents are used in treatment


To provide participants with current information on oncology and how it affects managed caredecision making, including coverage policy, reimbursement, and patient care.


This activity is intended for primary care physicians, oncologists, medical directors, and othermanaged care decision makers.


  • Describe the history and current coverage policy for oncology.
  • Name the challenges to controlling costs through better management of healthcare utilization foroncology services.
  • Explain strategies for improving quality of care for oncology patients.
  • Discuss the impact of consumer-driven healthcare on oncology resources.


The University of Cincinnati College of Medicine designates this activity for a maximum of 2Category 1 credits toward the AMA Physician's Recognition Award. Each physician shouldclaim only those hours that he/she actually spends in this educational activity.

The University of Cincinnati College of Medicine is accredited by the Accreditation Council forContinuing Medical Education (ACCME) to sponsor medical education for physicians. ReleaseDate: December 31, 2005. Expiration Date: December 31, 2006.


This program is supported by an educational grant from Genentech.


The contents of this supplement may include information regarding the use of products that may be inconsistentoutside the approved labeling for these products in the United States. Physicians should note that the use ofthese products outside current approved labeling is considered experimental and are advised to consult prescribinginformation for these products.